Together, these findings show that TAZ- and TEAD4-mediated coactivation of SOX2 expression is sufficient to induce stemness programs in HNSCC and offer the possibility that TAZ activation may mediate transcriptional programs that lead to the poor prognosis associated with 3q25-26 copy gain. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.